In the November/December 2015 issue of PharmaVOICE, Jeff Aroy comments on how the application of sensors, connectivity, and continuous monitoring can revolutionize drug development in some areas. To read the article, click here.
Life sciences considerations for investment treaty disputes
Greg Bell, Andrew Tepperman, and Justin Ho co-authored a chapter in the ninth edition of The Investment Treaty Arbitration Review. The chapter titled...